-
公开(公告)号：US09052326B2
公开(公告)日：2015-06-09
申请号：US13981666
申请日：2012-01-25
CPC分类号： G01N33/6872 , A61K38/16 , G01N33/6893 , G01N2333/4703 , G01N2800/323 , G01N2800/324 , G01N2800/52
摘要： The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
摘要翻译： 本发明涉及一种用于评估受试者患有心血管疾病的风险的方法，包括测量从所述受试者获得的体液样品中的IF1水平的步骤，其中EF1的水平与所述受试者的风险呈负相关 有心血管疾病。
-
公开(公告)号：US09945871B2
公开(公告)日：2018-04-17
申请号：US14694249
申请日：2015-04-23
CPC分类号： G01N33/6872 , A61K38/16 , G01N33/6893 , G01N2333/4703 , G01N2800/323 , G01N2800/324 , G01N2800/52
摘要： The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
-
公开(公告)号：US20070249555A1
公开(公告)日：2007-10-25
申请号：US11628941
申请日：2005-06-07
申请人： Ronald Barbaras , Bertrand Perret , Corrine Rolland , Francois Terce , Jean-Marie Boeynaems , Xavier Collet , Sebastien Jacquet , Laurent Martinez
发明人： Ronald Barbaras , Bertrand Perret , Corrine Rolland , Francois Terce , Jean-Marie Boeynaems , Xavier Collet , Sebastien Jacquet , Laurent Martinez
CPC分类号： A61K31/663
摘要： Use of N-alkyl-2-substituted ATP analogues, pharmaceutically acceptable salts, metabolites or prodrugs thereof, for the preparation of a medicament intended to be used in the prevention and/or the treatment of cardiovascular diseases, pharmaceutical compositions comprising such compounds and a method for screening such compounds.
摘要翻译： N-烷基-2-取代的ATP类似物，其药学上可接受的盐，代谢物或前体药物在制备用于预防和/或治疗心血管疾病的药物中的用途，包含这些化合物的药物组合物和 筛选此类化合物的方法。
-
公开(公告)号：US20130310315A1
公开(公告)日：2013-11-21
申请号：US13981666
申请日：2012-01-25
IPC分类号： G01N33/68
CPC分类号： G01N33/6872 , A61K38/16 , G01N33/6893 , G01N2333/4703 , G01N2800/323 , G01N2800/324 , G01N2800/52
摘要： The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
-
公开(公告)号：US20150226749A1
公开(公告)日：2015-08-13
申请号：US14694249
申请日：2015-04-23
CPC分类号： G01N33/6872 , A61K38/16 , G01N33/6893 , G01N2333/4703 , G01N2800/323 , G01N2800/324 , G01N2800/52
摘要： The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
摘要翻译： 本发明涉及一种用于评估受试者患有心血管疾病的风险的方法，包括测量从所述受试者获得的体液样品中的IF1水平的步骤，其中EF1的水平与所述受试者的风险呈负相关 有心血管疾病。
-
-
-
-
搜索结果
5 条记录 (耗时 0.01 秒)
